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Investigating the toxicology of intramuscular injected CNT-AB in mice followed by 
microwave hyperthermia. 
An Honors Thesis submitted in partial fulfillment of the requirements for Honors in 
The Department of Chemistry and Biochemistry. 
 
By 
Conner Clark 
Under the mentorship of Dr. Eric Gato 
ABSTRACT 
The advent of carbon nanotubes (CNTs) has led to a wide range of research in 
various fields including cancer therapy for targeting specific localized and site-specific 
treatment. Carbon nanotubes bound to tumor specific antibodies (Ab) offers specific 
treatment for cancer cells without affecting surrounding tissue. This treatment makes use 
of infrared absorptive properties of nanotubes to incinerate both the nanotube and its 
associated tumor in vivo. We seek to affirm the initial results of CNT in cancer therapy 
by investigating the toxicological effect in mice injected with CNT-Ab followed by 
microwave hypothermia. After 1-week post-injection, mice were sacrificed followed by 
the collection of blood serum, liver, kidney and other tissues for further analysis. 
Albumin, total protein, aspartate transferase (AST), and creatinine levels were assessed in 
the blood serum. Total protein concentration across the treatment groups was varied. 
There were no significant changes in albumin levels as compared to the control group. 
Group YE (.125 mg/ml anti-PSMA-MWCNT + Microwave) was found to have 
consistently high blood serum analyte levels indicative of impaired liver and kidney 
functioning. No other treatment groups seemed to have shown any evidence of impaired 
kidney function; however, groups YB (Microwave only), YF [.5 mg/ml anti-PSMA-
MWCNT (No Microwave)], and YG (.5 mg/ml plain MWCNT + Microwave) seemed to 
show indications of impaired liver function. Analysis of gene expression revealed a 
significant impact on the NF-KB inflammatory response pathway.  NF-KB gene was 
upregulated relative to controls in all treatment groups. These results seem to suggest 
marginal toxicity from the injection of ab-CNT followed by hyperthermia in mice 
subjects. 
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2 
Introduction 
Cancer is a cluster of diseases that involves abnormal and uncontrollable cell 
growth which has the potential to spread to other parts of the body. It is a genetic disease 
caused by the alteration of genes that control cell growth and division. With more than 
100 types of cancer, it is the second highest leading cause of death in the United States 
[1]. The complexities of cancer make the disease extremely difficult to treat once it has 
invaded more than one tissue type. Cancer treatments such as chemotherapy, radiation 
therapy, and immunotherapy have serious side effects and the potential for biological 
resistance. Existing efforts that target single cellular abnormalities have met many 
obstacles yet have been proven to be effective [2].  
 Prostate cancer is one of the most lethal malignancies to men, second to lung 
cancer. Roughly 1 in 9 men will be diagnosed with prostate cancer and 1 out of 41 will 
die from it. Options for treatment are commonly surgical resection, while the remaining 
alternatives such as chemotherapy and radiation therapy have large potential for healthy 
cell death and undesired side effects [3]. Other established targeting therapies can have 
great shortcomings and low success rates.  
Carbon nanotubes (CNTs) are nanostructured materials that are smaller than a 
single nanometer at one characteristic structural length [4].  Carbon nanotubes conjugated 
to antibodies (CNT-Abs) offers for specific binding to cancer cells without association to 
other normal cell types. This treatment makes use of the infrared absorptive properties of 
nanotubes to incinerate both the nanotube and its associated tumor in vivo thus 
diminishing or eliminating associated side effects of current cancer treatments that 
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damage surrounding tissues. The function of the CNT-Abs at the cellular level provides 
specialized targeting of desired cell types.  
Previous studies have shown that CNTs have the potential to trigger 
inflammation, cytotoxicity and oxidative stress; however, there is not yet a full 
understanding of the toxicity of CNTs [5]. Further studies have demonstrated that the 
degree of toxicity is dependent on the surface chemistry of the CNTs. Functionalized 
carbon-based nanomaterials opposed to pristine carbon-based nanomaterials are expected 
to present a greater dispersibility in an aqueous medium, which could increase the cell 
response. CNTs associated with any metal have been found to have a higher chance for 
negative reactions [6]. The direct interaction between carbon-based nanomaterials and the 
cell can enhance oxidative stress within the cell due to CNTs ability to stimulate the 
generation of reactive oxygen species (ROS), which can damage lipids, carbohydrates, 
proteins, and DNA. This oxidative stress has been implicated in the induction of 
inflammation in many studies examining CNTs both in vivo and in vitro [7]. 
Effectiveness of CNT treatment has also been found to be dependent on the tissue type. 
For instance, CNTs’ introduced to lung tissue had a significant negative impact on the 
elderly with respiratory problems [8]. 
This research seeks to affirm preliminary data about the effectiveness of CNT-
Abs for targeted cancer treatment and to explore potential systemic and localized impact 
of CNT-Ab treatment followed by microwave hyperthermia. The importance of this study 
could provide new treatment options for a variety of cancers that would offer specific and 
localized cancer treatment without the invasiveness of surgery or the risk of tissue 
damage as in chemotherapy and radiation. 
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Figure 1: Functionalized multiwalled carbon nanotube used. Red color indicates the 
associated prostate cancer specific antibodies. 
 
Materials and Methods 
 
Experimental Design 
Approximately 4-5 week old male mice were assigned to 8 different treatment 
groups, each group containing 6 mice. As specified in table 1, treatment groups vary in 
CNT concentration, microwave exposure, and presence of prostate cancer specific 
antibodies (Prostate membrane specific antigen-PSMA). The mice were injected with 
multiwalled carbon nanotubes (MWCNT) conjugated with cancer specific antibodies 
(CNT-Abs/ PSMA-MWCNT) subcutaneously into both right and left flank and 
microwaved at 150 watts for 5 seconds. After 1-week post-injection, blood samples were 
collected. Further, tissues such as liver, kidney, and brain tissue were obtained for future 
examination. 
Mice were housed at the Georgia Southern University Animal Facility (1176A 
Biological Sciences Fieldhouse). The animals were handled according to the principles 
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outlined in the ILAR’s (Institute or Laboratory Animal Research) Guide for Care and Use 
of Laboratory Animals. Study protocols were reviewed and approved by Institutional 
Animal Care and Use Committee (IACUC Protocol Approval # I18024). 
 
 
Table 1: Treatments assigned to each group of mice (Y group, one week post-injection). 
 
Sample Treatment 
A No Treatment 
B Microwave only 
C .125 mg/ml anti-PSMA-MWCNT (No Microwave) 
D .125 mg/ml plain MWCNT + Microwave 
E .125 mg/ml anti-PSMA-MWCNT + Microwave 
F .5 mg/ml anti-PSMA-MWCNT (No Microwave) 
G .5 mg/ml plain MWCNT + Microwave 
H .5 mg/ml anti-PSMA-MWCNT + Microwave 
 
 Serum samples were assayed to quantify systemic and localized impact of 
treatment. Further research onto the specific tissue types was conducted to analyze gene 
expression and the influence of treatment on immune and inflammatory responses. 
 
Serum Creatinine Assay 
The reagent was prepared to quantify creatinine using a 48 well plate. Reaction 
buffer was made up of a mixture of 1ml creatinine sodium borate, 3ml creatinine 
surfactant, and 2ml creatinine NaOH. A standard was then prepared using a series of 
dilutions of the creatinine standard and HPLC-grade water. Samples ranging from A 
through H (Table 1) were analyzed using guidelines provided by the assay manufacturer 
[Cayman Chemical, Creatinine (serum) Colorimetric Assay, Ann Arbor Mi; Cat# 
700460]. Approximately 15 l of each sample was added to the respective wells along 
with 100 l of creatinine reaction buffer and 100l of creatinine color reagent. The 
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absorbance of the solutions was read at 495nm after 1 minute and then 7 minutes while 
being incubated at room temperature. The creatinine concentrations were then determined 
via the standard curve.   
 
Serum Albumin Assay 
The level of albumin in serum was measured using a reagent kit provided by 
Pointe Scientific, Inc., (Canton, MI, Cat#: A7502-1L). Using guidelines provided by the 
kit manufacturer, albumin reagent was mixed with serum samples in their respective test 
tubes followed by incubation at room temperature. The UV spectrophotometer was 
blanked and then read and recorded at 630nm. Albumin concentrations were calculated 
using a standard curve generated by an albumin standard. 
 
Serum Liquid AST (Aspartate Aminotransferase) Assay 
Level of AST activity was also quantified in serum samples (Pointe Scientific, 
INC., Canton, MI, Cat#: A7561-450). Working reagents were pre-warmed followed by 
the addition of the respective serum samples using assay protocol provided by the kit 
manufacturer. Then the absorbance was read and recorded in a UV spectrophotometer at 
340nm.  Each sample was then returned to the incubator and absorbance was read again 
every minute for the next 2 minutes. The average difference in absorbance per minute 
was calculated and multiplied by the factor 1768 to yield IU/L. Samples were run at least 
thrice in duplicates.  
 
Tissue RNA Extraction 
  
7 
Total RNA was extracted from liver, kidney and brain tissues using Qiagen’s 
RNeasy mini RNA extraction kit. Approximately 20 to 30 milligrams of liver were 
weighed for samples A-H. Tissues were placed and homogenized in QIAzol Lysis 
reagent. Addition of gDNA eliminator solution and chloroform were performed followed 
by centrifugation at low temperature.  Next, the RNA supernatant was removed, passed 
through an RNeasy spin column, and then the column was cleaned using RWT and RPE 
buffer. Finally, RNA samples were eluted from the spin columns using RNase free water. 
The quality and concentration of the total RNA were examined with a Nanodrop (Thermo 
Scientific Nanodrop, 2000/2000c Spectrophotometer, Cat#:ND-2000c) nucleic acid 
spectrophotometer. RNA gel electrophoresis was also performed to evaluate the quality 
of the RNA. 
 
cDNA synthesis 
Complementary DNA (cDNA) was synthesized from total RNA samples using 
the Bio-Rad’s iScript Reverse Transcription Supermix for RT-qPCR (Hercules, CA, 
USA) following manufacturer guidelines.  
 
Gene Expression 
The expression of various genes related to inflammatory response in the treatment 
groups YA-YH was analyzed. Genes such as IL1B, IL6, PTSG2, TNF, and NFKB were 
analyzed using -actin as a control gene. The reaction mixture comprised of forward and 
reverse primers specific to the gene of interest (table 2), SsoFast EvaGreen Supermix 
(Bio-Rad, Hercules, CA, USA), nuclease free water and cDNA. Reaction mixture was 
  
8 
run on a Bio-Rad CFX96 Rt-PCR system to quantitatively measure the expression of 
mRNA transcripts.  
 
Table 2: Description of primers used for each gene studied.  
Gene Forward Primer Reverse Primer 
PTSG2 5’-GCGGGAACACAACAGAGTAT-3’ 
 
5’-GGACAGCCCTTCACGTTATT-3’ 
 
TNF-α 
 
5’-ACAAGGCTGCCCCGACTAT-3’ 5’-CTCCTGGTATGAAGTGGCAAATC-3’ 
 
IL-1β 
 
5’-TACCTATGTCTTGCCCGTGGAG-3’ 5’-ATCATCCCACGAGTCACAGAGG-3’ 
NF-kB 5’-AGCAGGATGCTGAGGATTCTG-3’ 5’-GGCAACTCTGTCCTGCACCTA-3’ 
 
IL-6 5’-GGAGTTTGTGAAGAACAACT-3’ 5’-CTAGGGTTTCAGTATTGCTC-3’ 
 
 
Data Analysis 
The statistical analysis of data was performed using analysis of variance 
(ANOVA). Albumin concentration, creatinine concentration, total protein concentration, 
and AST activity were evaluated for significant changes comparing the treated groups to 
the control group. Significant differences between the treatment groups were denoted as 
either *p < 0.05 or **p < 0.01 and data were presented as mean ± standard error. 
 
Results 
Quantification of Albumin, AST and Creatinine and Total Protein Levels in Serum 
An evaluation of the serum albumin concentration of the control and treatment 
groups were performed, which allowed a comparison of the differing treatment groups 
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and their systemic effects. Figure 1 illustrates the mean serum creatinine in mg/dl. Group 
YA (no treatment) is the control group. Compared to the control group, no significant 
change was noted in the treated groups.  
Shown in Figure 2 is the serum creatinine concentrations of all experimental 
groups. Creatinine concentrations of groups YB (Microwave only), YD (.125 mg/ml 
plain MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT + No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave) were significantly reduced when compared to the control mice. Compared to 
the control groups, YC (.125 mg/ml anti-PSMA-MWCNT + No Microwave) & YE (.125 
mg/ml anti-PSMA-MWCNT + Microwave) treatment groups did not show any 
significant differences. 
 Evaluation of AST was performed across treatment and control groups. Figure 3 
illustrates AST activity levels in mice for groups YA (No Treatment),YB (Microwave 
only), YC (.125 mg/ml anti-PSMA-MWCNT + No Microwave), YD (.125 mg/ml plain 
MWCNT + Microwave), YE (.125 mg/ml anti-PSMA-MWCNT + Microwave), YF (.5 
mg/ml anti-PSMA-MWCNT No Microwave), YG (.5 mg/ml plain MWCNT + 
Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + Microwave) for serum AST. 
Compared to YA (No Treatment), groups YB (Microwave only), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave) 
and YG (.5 mg/ml plain MWCNT + Microwave) showed significantly increased AST 
activity in blood serum.  On the contrary, YD (.125 mg/ml plain MWCNT + Microwave) 
and YH(.5 mg/ml anti-PSMA-MWCNT + Microwave) mice appeared to show 
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significantly reduced levels of serum AST activity. No change was observed in the YC 
(.125 mg/ml anti-PSMA-MWCNT + No Microwave) treated mice.  
Total protein concentration is reported in Figure 4. Serum total protein 
concentration values mirror that of the albumin concentration. Although the treated 
groups were either slightly lower or higher, these values were within the margin of error. 
None of the treatment groups when compared with the control mice showed any 
significantly elevated or diminished total protein levels.   
 
 
Figure 1: Mean Serum Albumin of treated mice. Treatment groups included: YA (No 
Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
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Figure 2: Mean Serum Creatinine in treated mice. Lower levels of creatinine were found 
in YB (Microwave only), YD (.125 mg/ml plain MWCNT + Microwave), YF (.5 mg/ml 
anti-PSMA-MWCNT No Microwave), YG (.5 mg/ml plain MWCNT + Microwave), and 
YH (.5 mg/ml anti-PSMA-MWCNT + Microwave) groups. Creatinine levels in YC (.125 
mg/ml anti-PSMA-MWCNT + No Microwave) and YE (.125 mg/ml anti-PSMA-
MWCNT + Microwave) groups were not altered significantly. 
 
 
 
 
Figure 3: Mean serum AST activity (IU/L) in treated mice. Treatment groups included; 
YA (No Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
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Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
 
 
Figure 4: Mean Serum Total Protein of treated mice. Levels of total protein in blood 
serum were relatively constant for all groups. Treatment groups included; YA (No 
Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
 
 
Expression of inflammatory genes in the Brain, Liver and Kidney Tissues 
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 Brain, hepatic, and renal relative expression of select inflammatory genes, IL1B, 
IL6, NF-KB, PTSG2, and TNF, were measured in each experimental group. A brief 
description of each of these genes is provided in Table 3.  
 Gene expression of select inflammatory genes in the liver tissues of treated mice 
are displayed in Figure 5. Genes IL1B and PTSG2 were not expressed for any of the 
treatment groups. All treatment groups had a downregulation in expression for IL6 and 
TNF compared to the control. Groups YD (.125 mg/ml plain MWCNT + Microwave) and 
YE (.125 mg/ml anti-PSMA-MWCNT + Microwave) had an upregulation for NFKB, 
while YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT No Microwave), YF 
(.5 mg/ml anti-PSMA-MWCNT No Microwave), and YG (.5 mg/ml plain MWCNT + 
Microwave) were all downregulated when compared to the control. 
 Presented in Figure 6 is the gene expression in brain tissue across treatment 
groups. Across treatment groups, gene IL1B was not expressed and genes IL6, PTSG2, 
and TNF had a downregulation compared to the control. For the gene NFKB all treatment 
groups were upregulated compared to the control group in brain tissue. 
 The expression of select inflammatory genes in kidney tissue is shown in Figure 7 
for all treatment groups. IL1B was not expressed for the treatment or control and gene 
TNF was down regulated across all treatment groups. Genes IL6 and PTSG2 were down 
regulated across treatment groups with exceptions to group YB (Microwave only) which 
was slightly upregulated. For the gene NFKB all treatment groups were upregulated 
compared to the control group.  
Results portray the effect of treatment on important immune responses and 
whether or not a response is induced. Figures 5, 6, and 7 illustrate relative expression in 
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liver, brain, and kidney tissues respectively. IL1B was not expressed in any tissues across 
treatment groups. Genes Il6, PTSG2, and TNF were all under expressed across treatment 
groups and tissue types. Gene NF-KB is of greatest interest due to the significant 
overexpression that most treatment groups portrayed across tissue types.  
 
 
 
 
Figure 5: Relative gene expression in liver of treated mice. Treatment groups included; 
YA (No Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
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Figure 6: Relative gene expression in brain of treated mice. Treatment groups included; 
YA (No Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
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Figure 7: Relative gene expression in kidney of treated mice. Treatment groups included; 
YA (No Treatment),YB (Microwave only), YC (.125 mg/ml anti-PSMA-MWCNT + No 
Microwave), YD (.125 mg/ml plain MWCNT + Microwave), YE (.125 mg/ml anti-
PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No Microwave), 
YG (.5 mg/ml plain MWCNT + Microwave) and YH (.5 mg/ml anti-PSMA-MWCNT + 
Microwave). 
 
Table 3: Description of genes studied including role, regulation, and signaling.  
 
Gene Description 
IL1B A member of the interleukin 1 cytokine family. The cytokine is produced by 
activated macrophages which is proteolytically processed to its active form 
by caspase. This cytokine is an important mediator of the inflammatory 
response, and is involved in a variety of cellular activities, including cell 
proliferation, differentiation, and apoptosis [9]. 
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IL6 This gene encodes a cytokine that functions in inflammation and the 
maturation of B cells. The protein is primarily produced at sites of acute and 
chronic inflammation, where it is secreted into the serum and induces a 
transcriptional inflammatory response through interleukin 6 receptor, alpha 
[10]. 
NFKB NFKB is a transcription regulator that is activated by various intra- and 
extra-cellular stimuli such as cytokines, oxidant-free radicals, and bacterial 
or viral products. Activated NFKB stimulates the expression of genes 
involved in a wide variety of biological functions. Inappropriate activation 
of NFKB has been associated with a number of inflammatory diseases [11]. 
PTGS2 This gene encodes the inducible isozyme PTGS2. It is regulated by specific 
stimulatory events and is responsible for the prostanoid biosynthesis 
involved in inflammation and mitogenesis [12]. 
TNF This gene encodes a multifunctional proinflammatory cytokine that belongs 
to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly 
secreted by macrophages. This cytokine is involved in the regulation of a 
wide spectrum of biological processes including cell proliferation, 
differentiation, and apoptosis. This cytokine has been implicated in a variety 
of diseases, including autoimmune diseases, insulin resistance, and cancer 
[13]. 
 
Discussion 
 Serum blood tests were conducted to study levels of creatinine, albumin, aspartate 
amino transferase (AST) and total protein within mice exposed to CNT conjugated 
antibodies. These assays provide insight into systemic impacts of the treatment including 
hepatotoxicity and nephrotoxicity, while investigation of gene expression provides 
insight into specific and localized effects on the kidney, brain, and liver tissues. 
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Creatinine is a waste product remaining from the metabolism of creatine 
phosphate in muscle. Creatinine assays reveal important information about kidney 
function and filtration rate as well. High levels of serum creatinine can thus indicate 
improper kidney function, decreased glomerular filtration rate and can also be indicative 
of intense exercise, dehydration, and high protein diets [14]. Mean serum creatinine 
levels of the treatment groups were significantly lower in comparison to the control mice 
with the exception of treatment group YE (.125 mg/ml anti-PSMA-MWCNT + 
Microwave) which was observed to have a much larger creatinine concentration. This 
indicates potential kidney impairment for the YE treatment group. Creatinine is formed 
largely in the muscles by the removal of water from creatine phosphate. While high 
levels of creatinine are not life threatening, it may be indicative of other underlying 
health issues such as chronic kidney disease. A study by Yadav and colleagues (2014) 
showed that serum creatinine levels are directly related to the severity of the disease and 
thus a great biomarker for kidney impairment [15].   
Albumin is a globular blood transport protein that is the most abundant protein 
found in blood. Albumin binds substances including water, calcium, sodium, potassium, 
fatty acids, hormones and others. In addition to being a nutrient carrier, it also serves to 
regulate the oncotic pressure of blood. Low levels of serum albumin can indicate liver 
damage, kidney disease, malabsorption, malnutrition, and malignancies while high levels 
of albumin typically indicate dehydration [16]. There were no notable deviations in 
albumin levels across treatment groups compared to the controls. 
Aspartate aminotransferase (AST) is an important enzyme in amino acid 
metabolism that is found predominantly in the liver, but also in smaller amounts in heart, 
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brain, muscle, and kidney tissues. AST levels serve as indicators of liver function and 
inflammation. Healthy individuals have naturally low AST levels, however when tissue 
that contains AST is damaged it is released into the blood leading to increased levels 
[17]. An increase in AST activity was found in groups YB (Microwave only), YE (.125 
mg/ml anti-PSMA-MWCNT + Microwave), YF (.5 mg/ml anti-PSMA-MWCNT No 
Microwave), and YG (.5 mg/ml plain MWCNT + Microwave) for serum AST. These 
results suggest that CNT-Ab exposure might be indicative of potential damage to liver 
function within these treatment groups. A study by Hennes and colleagues on pediatric 
patients with blunt abdominal trauma were able to identify hepatic injury using AST as a 
biomarker with 100% sensitivity and 93% specificity. They found that AST levels had a 
significant correlation with positive results on CT scans used to diagnose patients. 
Elevated AST levels do not have a direct impact on any system but are a reliable 
biomarker for liver damage [18]. 
Proteins are important building blocks for organs, muscles, hormones, and 
enzymes and are therefore essential to the overall health of an organism. Fluctuations in 
the number of proteins in blood serum can result in fatigue, weight loss, and 
inflammatory disease and can be indicative of underlying kidney or liver diseases. High 
protein levels can indicate inflammation, cancer, dehydration, or liver/kidney disease, and 
low protein levels can indicate malnutrition, malabsorption, congestive heart failure, and 
liver/kidney disease [19]. Levels of total protein in blood serum among treatment and 
control mice was unchanged.  
The evaluation of kidney and liver function is of great importance when 
determining toxicity of a certain substance or treatment. Both organs play key roles in 
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removing toxins from the body and maintaining a systemic equilibrium of vital nutrients 
needed for functioning [20]. Thus, determining the potential for hepatotoxicity and 
nephrotoxicity are imperative in determining the human health risk. The liver functions to 
filter the blood coming from the digestive tract before dissemination to the rest of the 
body among other metabolism and storage functions. The role of the kidney is to remove 
any waste from the blood to be passed in the urine and to maintain hydration and 
electrolyte levels [21]. Treatment group YE (.125 mg/ml anti-PSMA-MWCNT + 
Microwave treatment) was found to have consistently high creatinine, AST, and total 
protein levels, all suggesting toxicity in the liver and kidneys of exposed mice. No other 
treatment groups appeared to have shown levels of these biomarkers that may be 
indicative of toxicity. However, groups YB (Microwave only), YF (.5 mg/ml anti-PSMA-
MWCNT No Microwave), and YG (.5 mg/ml plain MWCNT + Microwave) had higher 
AST levels which may suggest impaired liver function. It is unclear why treatment group 
YE elicited such a response in the mice, yet groups YF and YG only showed signs of 
liver damage even though a greater amount of MWCNT’s were used for treatment.  
Investigating gene expression can reveal which genes are turned on or off in a 
specific cell type and can be used to quantify the gene’s relative expression.  The genes 
studied are described in table 3. These genes play important roles in the immune and 
inflammatory response. Measurement of these genes in brain, liver, and kidney tissues 
may provide information about whether a gene is overexpressed or under-expressed in 
treated groups.  
Gene IL1B was not expressed for the treatment or control groups in any of the 
tissues. Genes IL6, PTSG2, and TNF were down regulated for all treatment groups in the 
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brain, liver, and kidney tissues. The gene of greatest interest was NFKB which was highly 
expressed in all tissues for each treatment group. The magnitude of expression compared 
to the control suggests a significant upregulation in the expression of this inflammatory 
response gene. NFKB is a transcription regulator that is activated by various cellular 
stimuli such as cytokines, oxidant-free radicals, and bacterial or viral products. Activated 
NFKB stimulates the expression of genes involved in a wide variety of biological 
functions including response to infection. Inappropriate activation of NFKB has been 
associated with a number of inflammatory diseases [22]. Upregulation of this gene 
indicates a localized effect on these tissues that could be due to a number of cytotoxic 
factors including exposure to CNT-Ab plus microwave radiation.  
 
Conclusion 
In conclusion, group YE was found to have consistently high blood serum creatinine, 
AST, and total protein levels indicative of potential liver and kidney impairment. No other 
treatment groups were determined to have impaired kidney function; but groups YB, YF, and 
YG had higher AST levels which may suggest impaired liver function. Investigation of gene 
expression revealed an overexpression of the NFKB gene, which may impact the inflammatory 
response pathway. These results suggest that exposure to treatment may induce hepatotoxicity 
and nephrotoxicity. Future studies will involve the analysis of brain, liver, and kidney 
histopathology to fully understand the toxicological effects of CNT-Ab exposure.  
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